Allogene Therapeutics ALLO
$ 2.19
4.03%
Quarterly report 2024-Q3
added 11-07-2024
Allogene Therapeutics EV/EBITDA Ratio 2011-2024 | ALLO
Annual EV/EBITDA Ratio Allogene Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-7.54 | -18.2 | -10.5 | -4.1 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-4.1 | -18.2 | -10.1 |